Immutep Limited (IMM.AX)

AUD 0.23

(-6.12%)

Revenue Summary of Immutep Limited

  • Immutep Limited's latest annual revenue in 2022 was 3.5 Million AUD , up 1957.72% from previous year.
  • Immutep Limited's latest quarterly revenue in 2022 FY was 3.5 Million AUD , up 1957.72% from previous quarter.
  • Immutep Limited reported a annual revenue of 170.36 Thousand AUD in annual revenue 2021, down -95.59% from previous year.
  • Immutep Limited reported a annual revenue of 3.86 Million AUD in annual revenue 2020, down -48.4% from previous year.
  • Immutep Limited reported a quarterly revenue of 1.82 Million AUD for 2022 Q4, down 0.0% from previous quarter.
  • Immutep Limited reported a quarterly revenue of 3.5 Million AUD for 2022 FY, up 1957.72% from previous quarter.

Annual Revenue Chart of Immutep Limited (2022 - 2007)

Historical Annual Revenue of Immutep Limited (2022 - 2007)

Year Revenue Revenue Growth
2022 3.5 Million AUD 1957.72%
2021 170.36 Thousand AUD -95.59%
2020 3.86 Million AUD -48.4%
2019 7.48 Million AUD 5255.8%
2018 139.78 Thousand AUD -94.69%
2017 2.63 Million AUD -36.1%
2016 4.11 Million AUD 2251.72%
2015 175.05 Thousand AUD -90.66%
2014 1.87 Million AUD -22.79%
2013 2.42 Million AUD -20.86%
2012 3.06 Million AUD 101.73%
2011 1.52 Million AUD 0.0%
2010 - AUD -100.0%
2009 523.73 Thousand AUD 0.0%
2008 - AUD 0.0%
2007 - AUD 0.0%

Peer Revenue Comparison of Immutep Limited

Name Revenue Revenue Difference
AdAlta Limited 1.73 Million AUD -101.734%
Acrux Limited 5.09 Million AUD 31.139%
Race Oncology Limited 4 Million AUD 12.433%
Biome Australia Limited 13 Million AUD 73.051%
Botanix Pharmaceuticals Limited 601.82 Thousand AUD -482.52%
BTC Health Limited 16.36 Thousand AUD -21328.619%
Chimeric Therapeutics Limited 7.45 Million AUD 52.992%
CSL Limited 22.41 Billion AUD 99.984%
Clarity Pharmaceuticals Ltd 11.5 Million AUD 69.533%
Clinuvel Pharmaceuticals Limited 88.17 Million AUD 96.024%
EZZ Life Science Holdings Limited 66.44 Million AUD 94.724%
Hexima Limited - AUD -Infinity%
Memphasys Limited 60 Thousand AUD -5742.87%
Neuren Pharmaceuticals Limited 231.92 Million AUD 98.488%
Noxopharm Limited 2.4 Million AUD -46.055%
Prescient Therapeutics Limited 3.71 Million AUD 5.566%
Radiopharm Theranostics Limited 299.22 Thousand AUD -1071.589%
Starpharma Holdings Limited 8.28 Million AUD 57.706%
Tissue Repair Ltd 152.24 Thousand AUD -2202.76%
Biotron Limited - AUD -Infinity%
Alterity Therapeutics Limited 4.01 Million AUD 12.777%
Anatara Lifesciences Ltd - AUD -Infinity%
Bio-Gene Technology Limited 18.32 Thousand AUD -19036.037%
Zelira Therapeutics Limited 94.95 Thousand AUD -3592.099%
Patrys Limited 1.39 Million AUD -151.457%
Orthocell Limited 5.31 Million AUD 34.046%
Imugene Limited - AUD -Infinity%
PYC Therapeutics Limited 22.05 Million AUD 84.108%
Proteomics International Laboratories Limited 892.14 Thousand AUD -292.955%
Cynata Therapeutics Limited 2.31 Million AUD -51.393%
Arovella Therapeutics Limited 17 Thousand AUD -20521.894%
Nanollose Limited 12.5 Thousand AUD -27943.533%
Invex Therapeutics Ltd 1.21 Million AUD -189.19%
NeuroScientific Biopharmaceuticals Limited - AUD -Infinity%
Amplia Therapeutics Limited 4.45 Million AUD 21.268%
Island Pharmaceuticals Limited 1.25 Million AUD -180.105%
Nyrada Inc. - AUD -Infinity%
Telix Pharmaceuticals Limited 496.65 Million AUD 99.294%
Dimerix Limited 583.47 Thousand AUD -500.832%
PharmAust Limited - AUD -Infinity%
AnteoTech Limited 460.39 Thousand AUD -661.456%
Paradigm Biopharmaceuticals Limited 65.8 Thousand AUD -5227.845%
Recce Pharmaceuticals Ltd - AUD -Infinity%
Avecho Biotechnology Limited 473.55 Thousand AUD -640.305%
Actinogen Medical Limited 9.93 Million AUD 64.701%
Immuron Limited 4.9 Million AUD 28.496%
Argenica Therapeutics Limited 2.59 Million AUD -34.943%